1. Evaluation of gastric content in fasting patient during semaglutide use: an observational study.
- Author
-
Queiroz, Veronica Neves Fialho, Falsarella, Priscila Mina, Chaves, Renato Carneiro de Freitas, Francisco Neto, Miguel Jose, Silva, João Manoel, Araújo, Guilherme Freitas, Takaoka, Flávio, Pfeilsticker, Flávia Julie do Amaral, Mendes, Guilherme Falleiros, and Garcia, Rodrigo Gobbo
- Abstract
The evident influence of GLP-1 agonists as semaglutide on gastric emptying even in adherence to recommended fasting protocols instigates debates. To investigate the effect of semaglutide on gastric content by gastric ultrasonography in volunteers. Private hospital. The present study is an observational, cross-sectional, and single-center study. We included 30 consecutive volunteers aged ≥18 years who had undergone a minimum fasting period of 8 hours for solid foods and 2 hours for clear, residue-free liquids. The intervention group consisted of 15 volunteers who had used semaglutide within the last 7 days, whereas the control group consisted of 15 volunteers who had never used semaglutide. The main objective was to determine whether the stomach was full or not. Between June 2023 and August 2023, a total of 30 adult volunteers were included in the study, and no participant was excluded. The semaglutide group exhibited a higher prevalence of full stomach (11 of 15 [73%] versus 1 of 15 [7%], P <.001; adjusted to age P =.003). The semaglutide group also exhibited a higher prevalence of early satiety (10 of 15 [67%] versus 0 of 15 [0%], P <.001), loss of appetite (10 of 15 [67%] versus 0 of 15 [0%], P <.001), gastric fullness (8 of 15 [53%] versus 0 of 15 [0%], P =.002), and nausea (7 of 15 [47%] versus 1 of 15 [7%], P =.035). Additionally, there is no case in the semaglutide group with no gastric contents. The use of semaglutide is associated with full stomach even after appropriate overnight fasting. Semaglutide is also associated with increased gastrointestinal symptoms such as loss of appetite, early satiety, gastric fullness, and nausea. • To investigate the effect of semaglutide on gastric content by gastric ultrasonography. • The semaglutide group exhibited a higher prevalence of full stomach. • Higher prevalence of early satiety, loss of appetite, gastric fullness was observed. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF